Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Bruntsch

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.
Drugs|January 1, 1992
Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapyU Bruntsch, S Drechsler, E Hiller, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[An integrated program for chemotherapy and radiotherapy of inoperable small-cell bronchial carcinoma]R Osieka, S Seeber, U Bruntsch, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1986
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials groupU Bruntsch, P Dodion, W W Ten Bokkel Huinink, et al.
Deutsche Medizinische Wochenschrift (1946)|December 9, 1977
[Primary and secondary exploratory laparotomy and splenectomy in Hodgkin's disease (author's transl)]U Bruntsch, F Beersiek, F W Eigler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Deutsche Medizinische Wochenschrift (1946)|December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]A C Mayr, H J Senn, W M Gallmeier, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Onkologie|February 1, 1990
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trialH Köppler, K H Pflüger, I Eschenbach, et al.
Journal of Biological Response Modifiers|June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinomaU Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.
Drugs|January 1, 1992
Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapyU Bruntsch, S Drechsler, E Hiller, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[An integrated program for chemotherapy and radiotherapy of inoperable small-cell bronchial carcinoma]R Osieka, S Seeber, U Bruntsch, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1986
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials groupU Bruntsch, P Dodion, W W Ten Bokkel Huinink, et al.
Deutsche Medizinische Wochenschrift (1946)|December 9, 1977
[Primary and secondary exploratory laparotomy and splenectomy in Hodgkin's disease (author's transl)]U Bruntsch, F Beersiek, F W Eigler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Deutsche Medizinische Wochenschrift (1946)|December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]A C Mayr, H J Senn, W M Gallmeier, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Onkologie|February 1, 1990
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trialH Köppler, K H Pflüger, I Eschenbach, et al.
Journal of Biological Response Modifiers|June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinomaU Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Pageof 10